Back

Prognostic utility of a next-generation high-sensitivity cardiac troponin T assay compared to an established high-sensitivity cardiac troponin I assay in the general population

30 August 2026 (08:55 - 09:05)
Organised by: Logo
Congress Presentation Part of: Novel markers to prevent cardiovascular risk Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Raphael Twerenbold

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

5 More presentations in this session

Presentation thumbnail
Prevalence of clinically actionable hsCRP and implications for statin eligibility and residual ASCVD risk in the United States
Doctor N. Chiu (Boston, US)
Abstract Slides
Presentation thumbnail
Gene-exposure interactions regulate cytokine-mediated chronic inflammation and cardiac remodeling
Doctor M. Coriano' (London, GB)
Abstract Slides
Presentation thumbnail
Longitudinal hsCRP assessment in routine care refines residual inflammatory risk estimates
Professor D. Wolf (Freiburg, DE)
Abstract Slides
Presentation thumbnail
Proposition of reference tables for a novel hs-cTnT assay to define “normal” considering relevant determinants in the general population
Doctor J. Lehmacher (Hamburg, DE) Professor R. Twerenbold (Hamburg, DE)
Abstract Slides
Presentation thumbnail
Treatment-adjusted detection and outcome risk for familial hypercholesterolaemia: dual external validation in 4,028 genetically confirmed cases across specialist and UKbiobank settings
Doctor N. Genedy (Cardiff, GB)

Access the full session

Session thumbnail
Novel markers to prevent cardiovascular risk
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 08:55 CET
You may be interested in
thumbnail
Congress Presentation
High-sensitivity cardiac troponin I and NT-proBNP and their relationship to heart failure in the European BiomarCaRE population
1 September 2019
thumbnail
Congress Presentation
Comparative predictive value of troponin I and troponin T for in-hospital ischemic and bleeding events in acute coronary syndrome
30 August 2025
thumbnail
Congress Presentation
Cardiac troponins and anthracycline cardiotoxicity: a sub study of the PROACT trial; are all assays made equal?
21 June 2025
thumbnail
Congress Presentation
Prognostic value of baseline wasted myocardial work and serum troponines in severe AS patients referred for TAVR
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources